Cargando…
Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus
Modified measles virus (MV) has effective oncolytic activity preclinically and is currently being investigated in clinical trials for various types of cancer. We investigated the use of cystine knot proteins (CKPs) to direct MV activity. CKPs are short polypeptides that bind their targets with high...
Autores principales: | Lal, Sangeet, Raffel, Corey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771132/ https://www.ncbi.nlm.nih.gov/pubmed/29367943 http://dx.doi.org/10.1016/j.omto.2017.09.005 |
Ejemplares similares
-
Advances in the design and development of oncolytic measles viruses
por: Hutzen, Brian, et al.
Publicado: (2015) -
Retargeting of Viruses to Generate Oncolytic Agents
por: Verheije, M. H., et al.
Publicado: (2012) -
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016) -
In Vivo Safety, Biodistribution and Antitumor Effects of uPAR Retargeted Oncolytic Measles Virus in Syngeneic Cancer Models
por: Jing, Yuqi, et al.
Publicado: (2014) -
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin
por: Hutzen, Brian, et al.
Publicado: (2014)